Hunterbrook Media released a short report on diabetes-focused DexCom Inc. DXCM, citing that the company sold the "adulterated" device.Benzinga reached out to DexCom for comments and is yet to hear from them.A surprise FDA inspection found Dexcom made an unauthorized design change to the G7 glucose monitoring device, with internal tests showing worse accuracy across the board.Despite this, the company sold the device, drawing FDA scrutiny. Executives have since departed as patient complaints climbed, rivals ...

We recently published All-Time Rush: 8 of 10 Big Names Hit Fresh Record Highs. Hologic Inc. (NASDAQ:HOLX) is one of the best performers on Wednesday. Shares of Hologic Inc. rallied by 7.69 percent on Wednesday to close at $68.20 as investors repositioned portfolios amid reports that it was again in talks with two investment companies for a potential sale. According to a report by Bloomberg, Hologic Inc. (NASDAQ:HOLX) has received a new acquisition offer from Blackstone Inc. and TPG Inc. after earlier neg ...

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Inspire Medical Systems, Inc. stands tenth among them. Inspire Medical Systems, Inc. (NYSE:INSP), a leader in minimally invasive devices for obstructive sleep apnea (OSA), reported challenges in the commercial rollout of its new Inspire V system. Delays in onboarding treatment centers and navigating reimbursement processes have slowed full patient adoption, with some patients still using the older Inspire I ...

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Integer Holdings Corporation (NYSE:ITGR), a global contract development and manufacturing organization specializing in medical devices, reported solid growth in 2025. Q2 sales rose 11% to $476 million, driven by new product launches in the electrophysiology and neurovascular markets. The Cardio & Vascular segment led the surge with 24% growth, while the Cardiac Rhythm & Neuromodulation segment saw modest ga ...

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Haemonetics Corporation is one of them. Haemonetics Corporation (NYSE:HAE), a global leader in blood and plasma management technologies, continues to advance healthcare efficiency through innovative medical devices. In 2025, the company launched the PerQseal Elite vascular closure system, receiving European CE Mark approval. This fully bioresorbable, sutureless device is designed for large-bore vascular ac ...

Key Takeaways Hologic's Diagnostics faces pressure from China's challenges and reduced HIV testing funding in Africa.Hologic's International Surgical increased about 25% in Q3 2025, with NovaSure thriving overseas.HOLX's Panther platform hits record use; Genius digital diagnostics expands globally with strong feedback. Expanding internationally is a key part of Hologic’s (HOLX) growth strategy, though it isn’t immune to the macroeconomic risks that come with it. The company’s Diagnostics segment outside the ...

Key Takeaways BAX launched its FDA-cleared Connex 360 monitor, now available for U.S. hospitals and health systems.The device supports faster vitals capture and EMR integration via Baxter's cloud-based DeviceBridge platform.Connex 360 is set to boost BAX's Front Line Care unit within the Healthcare Systems & Technologies segment.On Tuesday, Baxter International Inc. (BAX) launched its next-generation patient monitoring device, the Welch Allyn Connex 360 Vital Signs Monitor. The Connex 360 monitor has receiv ...

Key Takeaways AVNS acquired Nexus Medical to expand its Specialty Nutrition Systems business.The deal adds TKO connector to AVNS' portfolio, reducing occlusions and infection risks in IV therapy.The acquisition is cash-funded and immediately accretive to AVNS revenues and EPS.Avanos Medical, Inc. (AVNS) recently announced that it has acquired Nexus Medical, LLC, a privately held device maker based in Lenexa, KS, to expand its footprint in critical care for nutrition and medication delivery. The move strengt ...

Key Takeaways Alcon unveiled UNITY VCS study results showing superior efficiency in cataract and vitreoretinal surgery.UNITY VCS outperformed CONSTELLATION with 16% workflow efficiency and faster setup and teardown times. UNITY VCS cut cataract turnover 6% versus CENTURION, with 35% less energy use and 8% less ultrasound time. Alcon (ALC) unveiled results from time and motion studies demonstrating superior efficiency with the UNITY Vitreoretinal Cataract System (VCS) for vitreoretinal and cataract surgery c ...

EDEN PRAIRIE, Minn., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc., a fluid management company, today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 12,415,021 on September 16, 2025, based on Application No. 18/298,860. The patent relates to the use of one or more hemolysis sensors with extracorporeal blood filtration systems—such as ultrafiltration therapy and continuous renal replacement therapy (CRRT)—to help detect and localize red blood cell destruction occu ...